Kaletra
Product Images NDC 68258-1972

5 FDA label images from Dispensing Solutions, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Kaletra (NDC 68258-1972). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ndc 68258-1972-01 (Ndc 68258 1972 01 Abbott)

Ndc 68258-1972-01 (Ndc 68258 1972 01      Abbott)
Packaging label for Kaletra 200 mg/50 mg film-coated tablets containing 120 tablets per container. The label includes manufacturer information (Abbott Pharmaceuticals PR Ltd.), dispensing instructions, warnings, and identifies active ingredients lopinavir 200 mg and ritonavir 50 mg per tablet. The label shows NDC 68258-1972-01 and product number 1K0194, with dispensing exclusively by Dispensing Solutions, Inc.*
FDA Label Image

Body Surface Area Equation. (Kaletra Tablets Bsacalculation)

Body Surface Area Equation. (Kaletra Tablets Bsacalculation)
Chemical structure diagram depicting a formula involving body surface area (BSA) calculated using height in centimeters and weight in kilograms, shown as the square root of (Ht (cm) x Wt (kg)) divided by 3600.*
FDA Label Image

Figure Displays Steady-state Plasma Concentrations For Lopinavir And Ritonavir. (Kaletra Tablets Oral Figure1)

Figure Displays Steady-state Plasma Concentrations For Lopinavir And Ritonavir. (Kaletra Tablets Oral Figure1)
A line graph showing concentration (µg/mL) over time (hours) for two substances, Lopinavir and Ritonavir, including 95% confidence intervals. Lopinavir concentrations peak around 4-6 hours and then decline, while Ritonavir concentrations remain much lower throughout the 12-hour period.*
FDA Label Image

Chemical Structure For Lopinavir. (Kaletra Tablets Oral Structure1)

Chemical Structure For Lopinavir. (Kaletra Tablets Oral Structure1)
Chemical structure of the active ingredient in Kaletra. The image depicts a detailed molecular diagram showing various chemical groups and bonds characteristic of this pharmaceutical compound.*
FDA Label Image

Chemical Structure For Ritonavir. (Kaletra Tablets Oral Structure2)

Chemical Structure For Ritonavir. (Kaletra Tablets Oral Structure2)
Chemical structure diagram of the active ingredient in Kaletra, showing its molecular components including rings, functional groups, and various chemical bonds arranged in a complex configuration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.